Zhejiang Xinguang Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
Zhejiang Xinguang Pharmaceutical has a total shareholder equity of CN¥817.9M and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥892.5M and CN¥74.5M respectively. Zhejiang Xinguang Pharmaceutical's EBIT is CN¥30.3M making its interest coverage ratio -2.1. It has cash and short-term investments of CN¥669.6M.
Key information
0%
Debt to equity ratio
CN¥0
Debt
Interest coverage ratio | -2.1x |
Cash | CN¥669.61m |
Equity | CN¥817.92m |
Total liabilities | CN¥74.53m |
Total assets | CN¥892.45m |
Recent financial health updates
No updates
Recent updates
Earnings Not Telling The Story For Zhejiang Xinguang Pharmaceutical Co., Ltd. (SZSE:300519) After Shares Rise 38%
Oct 18Zhejiang Xinguang Pharmaceutical (SZSE:300519) Has Announced That Its Dividend Will Be Reduced To CN¥0.40
May 26Calculating The Intrinsic Value Of Zhejiang Xinguang Pharmaceutical Co., Ltd. (SZSE:300519)
Apr 16Zhejiang Xinguang Pharmaceutical Co., Ltd.'s (SZSE:300519) Low P/E No Reason For Excitement
Feb 26Financial Position Analysis
Short Term Liabilities: 300519's short term assets (CN¥753.7M) exceed its short term liabilities (CN¥65.5M).
Long Term Liabilities: 300519's short term assets (CN¥753.7M) exceed its long term liabilities (CN¥9.0M).
Debt to Equity History and Analysis
Debt Level: 300519 is debt free.
Reducing Debt: 300519 had no debt 5 years ago.
Debt Coverage: 300519 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 300519 has no debt, therefore coverage of interest payments is not a concern.